Fulltext

How European cardiologists perceive the role of calcium antagonists in follow-up after myocardial infarction

Opie, L. H. ; Lüscher, T. F. ; Ferrari, R. ; Hansen, J. Fischer

In: European Heart Journal, 1997, vol. 18, p. 134-138

Ajouter à la liste personnelle
    Titre
    • How European cardiologists perceive the role of calcium antagonists in follow-up after myocardial infarction
    Auteur
    • Opie, L. H.. Heart Research Unit and Hypertension Clinic, Department of Medicine, University of Cape Town, Cape Town, South Africa, Zürich, Switzerland, Brescia, IRCCS, Gussago, Brescia, Italy, Denmark
    • Lüscher, T. F.. University Hospital Zürich, Switzerland
    • Ferrari, R.. Chair of Cardiology, University of Brescia Brescia, IRCCS Salvatore Maugeri Foundation Gussago, Brescia, Italy
    • Hansen, J. Fischer. Department of Cardiology, Hvidovre Hospital, University of Copenhagen Denmark
    Type de document
    • Postprint
    Identifiant OAI-PMH
    • oai:doc.rero.ch:304372
    Summary
    About one hundred European cardiologists discussed the role of calcium antagonists in the follow-up management of myocardial infarction, β-blockers are the treatment of choice. Where these are contra-indicated or otherwise unsuitable, many clinicians would use a non-dihydropyridine calcium antagonist alone or in combination with an ACE inhibitor. There is broad agreement that calcium antagonists should not be used in patients with concomitant left ventricular failure. Cholesterol estimation in post-infarction patients is essential